Header Logo

Thandeka

Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Scheepers C, Bekker V, Anthony C, Richardson SI, Oosthuysen B, Moyo T, Kgagudi P, Kitchin D, Nonyane M, York T, Mielke D, Mabvakure BM, Sheng Z, Lambson BE, Ismail A, Garrett NJ, Abdool Karim SS, Shapiro L, Williamson C, Morris L, Moore PL. Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape. Cell Rep. 2020 11 24; 33(8):108430. PMID: 33238131; PMCID: PMC7723817.
      Citations: 10     Fields:    Translation:HumansCells
    2. Moyo T, Guleid FH, Schomaker M, Williamson C, Dorfman JR. HIV-1 Subtype C Tier 3 Viruses Have Increased Infectivity Compared to Tier 2 Viruses. AIDS Res Hum Retroviruses. 2020 12; 36(12):1010-1019. PMID: 32935560.
      Citations:    Fields:    Translation:HumansCells
    3. Moyo T, Kitchin D, Moore PL. Targeting the N332-supersite of the HIV-1 envelope for vaccine design. Expert Opin Ther Targets. 2020 06; 24(6):499-509. PMID: 32340497; PMCID: PMC7530370.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    4. Ferreira RC, Grant OC, Moyo T, Dorfman JR, Woods RJ, Travers SA, Wood NT. Structural Rearrangements Maintain the Glycan Shield of an HIV-1 Envelope Trimer After the Loss of a Glycan. Sci Rep. 2018 10 09; 8(1):15031. PMID: 30302011; PMCID: PMC6177452.
      Citations: 12     Fields:    Translation:HumansCells
    5. Moyo T, Ereño-Orbea J, Jacob RA, Pavillet CE, Kariuki SM, Tangie EN, Julien JP, Dorfman JR. Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11. J Virol. 2018 07 15; 92(14). PMID: 29618644; PMCID: PMC6026760.
      Citations: 9     Fields:    Translation:HumansCells
    6. Moyo T, Ferreira RC, Davids R, Sonday Z, Moore PL, Travers SA, Wood NT, Dorfman JR. Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies. Virology. 2017 01 15; 501:12-24. PMID: 27846415.
      Citations: 6     Fields:    Translation:HumansCells
    7. Jacob RA, Moyo T, Schomaker M, Abrahams F, Grau Pujol B, Dorfman JR. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. J Virol. 2015 May; 89(10):5264-75. PMID: 25673728; PMCID: PMC4442498.
      Citations: 18     Fields:    Translation:HumansCells
    Moyo's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (32)
    Explore
    _
    Co-Authors (5)
    Explore
    _
    Similar People (60)
    Explore
    _